UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-QSB -- QUARTERLY OR TRANSITIONAL REPORT
(Added by 34-30968, eff. 8/13/93 as amended)
(Mark One)
[ x ] QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES
EXCHANGE ACT OF 1934
For the quarterly period ended JUNE 30, 1996
[ ] TRANSITION REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES
EXCHANGE ACT OF 1934
For the transition period from to
Commission file number 0-17032
PROTEIN DATABASES, INC.
- -----------------------------------------------------------------------------
(Exact name of small business issuer as specified in its charter)
DELAWARE 13-3186604
- ------------------------------- --------------------------
(State or other jurisdiction of (I.R.S. Employer
incorporation or organization Identification No.)
405 OAKWOOD ROAD, HUNTINGTON STATION, NEW YORK 11746
- ---------------------------------------------- --------------------------
(Address of principle executive offices) (Zip Code)
(516)-673-3939
- -------------------------
Issuer's telephone number
_______________________________________________________________________
(Former name, former address and former fiscal year, if changed since
last report)
Check whether the issuer (1) filed all reports required to be filed by
Section 13 or 15(d) of the Exchange Act during the past 12 months
(or for such shorter period that the registrant was required to file
such reports) , and (2) has been subject to such filing requirements
for the past 90 days. Yes No.
x
--- ---
State the number of shares outstanding of each of the issue's classes
of common equity, as fo the latest practicable date.
Class Outstanding at June 30, 1996
- ---------------------------- ----------------------------
Common Stock $.01 par value 1,459,724
<PAGE>
PART II - OTHER INFORMATION
Item 6. Exhibits and Reports of Form 8-K
( a ) Exhibits: EX-27
( b ) Reports on Form 8-K: There were no reports on Form 8-K
filed by the Company during the three months ended
June 30, 1996
<PAGE>
INDEX TO EXHIBITS
27 - FINANCIAL DATA SCHEDULE
FINANCIAL DATA SCHEDULE EXHIBIT 27
WARNING: THE EDGAR SYSTEM ENCOUNTERED ERROR(S) WHILE PROCESSING THIS SCHEDULE.
<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM
PROTEIN DATABASES, INC'S JUNE 30, 1996 FINANCIAL STATEMENTS AND IS
QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
<NAME> PROTEIN DATABASES, INC.
<S> <C>
<PERIOD-TYPE> 3-MOS
<FISCAL-YEAR-END> DEC-31-1996
<PERIOD-END> JUN-30-1996
<CASH> 280,596
<SECURITIES> 0
<RECEIVABLES> 397,614
<ALLOWANCES> 0
<INVENTORY> 44,758
<CURRENT-ASSETS> 740,303
<PP&E> 991,345
<DEPRECIATION> (708,598)
<TOTAL-ASSETS> 1,036,570
<CURRENT-LIABILITIES> 158,562
<BONDS> 0
0
0
<COMMON> 14,597
<OTHER-SE> 863,411
<TOTAL-LIABILITY-AND-EQUITY> 1,036,570
<SALES> 909,349
<TOTAL-REVENUES> 909,349
<CGS> 349,089
<TOTAL-COSTS> 1,361,236
<OTHER-EXPENSES> 0
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 0
<INCOME-PRETAX> (451,887)
<INCOME-TAX> 0
<INCOME-CONTINUING> (451,887)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (451,887)
<EPS-PRIMARY> (.31)
<EPS-DILUTED> (.31)
</TABLE>
